Literature DB >> 6363661

Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis.

C H Pai, F Gillis, E Tuomanen, M I Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6363661     DOI： 10.1016/s0022-3476(84)81020-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  12 in total

Review 1.  Guidelines for managing acute gastroenteritis based on a systematic review of published research.

Authors:  M S Murphy
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 2.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Yersinia enterocolitica sepsis in a 3-week-old child.

Authors:  E C Thompson
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

4.  Probable transmission of Yersinia enterocolitica from a pet dog with diarrhoea to a 1-year-old infant.

Authors:  D J Hetem; M Pekelharing; S F T Thijsen
Journal:  BMJ Case Rep       Date:  2013-08-16

Review 5.  Acute gastroenteritis in children : what role for antibacterials?

Authors:  Nopaorn Phavichitr; Anthony Catto-Smith
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Foodborne Illnesses.

Authors:  Christopher J. Gill; Davidson H. Hamer
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

7.  Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

Authors:  M A Preston; S Brown; A A Borczyk; G Riley; C Krishnan
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Small Intestinal Infections.

Authors:  Saurabh Mehandru; Edmund J. Bini
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

9.  Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.

Authors:  Juraj Bosák; Lenka Micenková; Martin Vrba; Alena Ševčíková; Daniela Dědičová; Debora Garzetti; David Šmajs
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Clinical aspects and self-reported symptoms of sequelae of Yersinia enterocolitica infections in a population-based study, Germany 2009-2010.

Authors:  Bettina M Rosner; Dirk Werber; Michael Höhle; Klaus Stark
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.